Jove
Visualize
Contact Us

Witold Rybka

5PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Dec 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.

Gareth P Gregory, Shaji Kumar, Ding Wang

|May 21, 2021
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang

|Apr 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang

|Jun 02, 2020
A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia.

Stephen A Strickland, Xin Victoria Wang, Jan Cerny

|Sep 20, 2018
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.

Liru Wang, Bei Jia, David F Claxton

Pageof 1

Frequent Collaborators

3 joint publications

Hillard M Lazarus

2 joint publications

Mary-Elizabeth Percival

2 joint publications

Marcos de Lima

2 joint publications

Partow Kebriaei

2 joint publications

Nelli Bejanyan

2 joint publications

Vijaya Bhatt

2 joint publications

Paul Castillo

2 joint publications

Saurabh Chhabra

2 joint publications

Zachariah DeFilipp

2 joint publications

Michael Grunwald

Frequent Collaborators

3 joint publications

Hillard M Lazarus

2 joint publications

Mary-Elizabeth Percival

2 joint publications

Marcos de Lima

2 joint publications

Partow Kebriaei

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.2K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

29.9K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.2K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

29.9K
See more related videos